Migalastat hydrochloride
Modify Date: 2024-01-03 05:39:54
Migalastat hydrochloride structure
|
Common Name | Migalastat hydrochloride | ||
|---|---|---|---|---|
| CAS Number | 75172-81-5 | Molecular Weight | 199.63300 | |
| Density | N/A | Boiling Point | 382.7ºC at 760 mmHg | |
| Molecular Formula | C6H14ClNO4 | Melting Point | 260ºC | |
| MSDS | USA | Flash Point | 185.2ºC | |
Use of Migalastat hydrochlorideMigalastat hydrochloride (1-Deoxygalactonojirimycin hydrochloride) is a potent and competitive inhibitor of α-galactosidase A (α-Gal A) with an IC50 of 0.04 μM for human α-Gal A. |
| Name | deoxygalactonojirimycin, hydrochloride |
|---|---|
| Synonym | More Synonyms |
| Description | Migalastat hydrochloride (1-Deoxygalactonojirimycin hydrochloride) is a potent and competitive inhibitor of α-galactosidase A (α-Gal A) with an IC50 of 0.04 μM for human α-Gal A. |
|---|---|
| Related Catalog | |
| Target |
IC50: 0.04 μM (human α-Gal A)[1];Ki: 0.04 μM (human α-Gal A)[1] |
| In Vitro | Both IC50 and Ki values of migalastat hydrochloride toward human lysosomal a-Gal A are 0.04 μM[1]. |
| In Vivo | Fabry disease is an X-linked recessive disorder caused by the deficient activity of α-galactosidase A. α-Gal A activity in heart, kidney, spleen, and liver is increased dose- and time-dependently in transgenic mice that express human mutant alpha-Gal A with migalastat hydrochloride treatment. The half-life of DGJ is less than 1 day in all major issues and that of the enzyme synthesized during the DGJ treatment period is approximately 4 days[2]. Oral administration of migalastat hydrochloride reduces tissue GL-3 in fabry transgenic mice, and in urine and kidneys of some FD patients. Oral administration of migalastat hydrochloride to transgenic mice reduces elevated lyso-Gb3 levels up to 64%, 59%, and 81% in kidney, heart, and skin, respectively, generally equal to or greater than observed for GL-3[3]. |
| Animal Admin | Mice: Migalastat hydrochloride is dissolved in drinking water. Age-matched male homozygous TgM, TgM/KO, and nontransgenic (Non-Tg) C57BL/6 mice are supplied drinking water containing DGJ ad libitum. Body weight is monitored weekly during the DGJ treatment period. Average daily DGJ dosage is estimated based on the consumption of drinking water. Mice fed drinking water containing DGJ at 0.05 mM typically received DGJ at approximately 3 mg/kg body weight/day[2]. |
| References |
| Boiling Point | 382.7ºC at 760 mmHg |
|---|---|
| Melting Point | 260ºC |
| Molecular Formula | C6H14ClNO4 |
| Molecular Weight | 199.63300 |
| Flash Point | 185.2ºC |
| Exact Mass | 199.06100 |
| PSA | 92.95000 |
|
Paulsen, H., et al.
Chem. Ber. 113 , 2601, (1980)
|
| (1R,3R,4R,5S)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidinium chloride |
| 1,5-dideoxy-1,5-imino-D-glucitol hydrochloride |
| 1-Deoxymannojirimycinehydrochloride |
| DEOXYMANNONOJIRIMYCIN HCL |
| (+)-(2R,3R,4R,5S)-2-hydroxymethyl-3,4,5-trihydroxypiperidine hydrochloride |
| DEOXYMANNOJIRIMYCIN,HYDROCHLORIDE |
| (+)-1-deoxynojirimycin hydrochloride |
| 1-DEOXYMANNOJIRIMYCIN HCL |
| DMM |
| DEOXYMANNOJIRIMYCIN HCL |
| DMJ,HYDROCHLORIDE |
| 1-DeoxymannojirimycineHCl |
| Migalastat (hydrochloride) |